Announced Thu, 2 Jul · 18:32 IST

EGM approves preferential equity share issuance

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.8%1-day move
₹78.60
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.8-8.4-12.2-16.0-15.4-10.2-11.0
Up moveDown movePending
AI summary

Novelix Pharmaceuticals held an EGM on July 1, 2026. Shareholders approved a special resolution to issue equity shares on a preferential basis with 99.9999 percent votes in favor (about 1.05 crore votes). Only 10 votes were cast against. Of 3,235 eligible shareholders, 95 participated via remote e-voting and e-voting during the meeting. Promoters voted fully in favor (87.02 lakh shares), suggesting their participation in the allotment. The preferential issue will lead to equity dilution for existing public shareholders.

Likely market impact

Equity dilution expected from preferential share issuance. Promoters fully backed the resolution, indicating likely insider participation in the allotment.